Skip to content
You are here:
Home
Contact Us
Contact Us
Today
marketing@vxpharma.com
Support & information
Oxford, United Kingdom
Office location
Engage With Us
"
*
" indicates required fields
Select Your Business Status:
*
Startup or Public Institution
Established Business
Select a Service:
*
Business Strategy & Planning
Capital Solutions
Clinical Development Solutions
Select a Clinical Service Area:
*
Select Your Clinical Service Area
Specified Services
Full Service
Specify Services:
*
Medical Writing
Regulatory Support
Clinical Execution
Laboratory Procedures
Data Management
Site Monitoring & Audit (CRO Services)
Select Therapeutic Area:
*
Select Your Therapeutic Area
Infectious Disease (Vaccines & Therapeutics)
Healthy Volunteers
Autoimmune Disorders
Chronic Metabolic Disorders
Chronic Respiratory Disorders
Musculoskeletal Disorders
Other
Select Your Indication:
*
Human Immunodeficiency Virus (HIV)
Tuberculosis (TB)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Respiratory Synctical Virus (RSV)
Influenza (Flu)
Human Papillomavirus (HPV)
Herpes Zoster Virus (Shingles)
Meningococcal Bacteria (Bacterial Meningitus & Blood Infections)
Pneumococcal Bacteria (Pneumonia & Blood Infections)
Select Your Indication:
*
Bioequivalence and Bioavailability
First-in-Man Safety (SAD & MAD)
Drug-Drug Interaction
Food Effect
QT/QTc
Select Your Indication:
*
Atopic Dermatitis (AD or Eczema) and Psoriasis
Crohn's Disease and Ulcerative Colitis (IBD)
Rheumatoid Arthritis (RA)
Select Your Indication:
*
Diabetes (Type 1 and 2)
Hypercholesterolemia and Hyperlipidaemia
Cardiovascular Complications
Atherosclerosis (Narrowing/Hardening of Arteries)
Coronary Artery Stenosis (Heart Attack)
Carotid Artery Stenosis (Stroke)
Peripheral Artery Disease
Select Your Indication:
*
Asthma (Complicated and Uncomplicated)
Chronic Obstructive Pulmonary Disease (COPD)
Allergic Rhinitis (Hay Fever)
Select Your Indication:
*
Osteoarthritis (OA)
If "other" - please specify:
*
Full Name
*
Email Address:
*
Contact Number:
*
Position/Occupation:
*
Company Name:
*
Organisation Type:
*
Select Your Organisation Type
Large Pharma
Mid-sized Pharma
Emerging Biopharma (EBP)
Public Research Institution
CRO
Trial Site or Network
SMO
Other
Specify Organisation Type:
*
Country:
*
Select Your Country
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo, Democratic Republic of the
Congo, Republic of the
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Côte d'Ivoire
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini (Swaziland)
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine, State of
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Romania
Russia
Rwanda
Réunion
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
US Minor Outlying Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Ã…land Islands
Terms & Conditions
*
- By submitting this form, I understand and agree to the
Terms & Conditions
.
Protected by reCaptcha
Comments
This field is for validation purposes and should be left unchanged.
Go to Top
Home
About Us
Start-Up Business
Established Business
Business Strategy & Planning
Capital Solutions
Clinical Development Solutions
- Therapeutic Areas
- Service Areas
Enquire Now
Busines Strategy & Planning
Investment Facilitation
Clinical Development Stratergy
Clinical Development Execution
